Old Web
English
Sign In
Acemap
>
Paper
>
miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLC.
miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLC.
2021
Cristina Borzi
Elisa Caiola
Monica Ganzinelli
Giovanni Centonze
Mattia Boeri
Massimo Milione
Massimo Broggini
Gabriella Sozzi
Massimo Moro
Keywords:
poor prognosis
tumor cells
Epigenetics
Medicine
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
12
References
0
Citations
NaN
KQI
[]